ANI Pharmaceuticals

ANI Pharmaceuticals ANIP Stock

$74.17   -1.566030%
Add to favorites
Market Cap
$1.70B
LOW - HIGH [24H]
$74.08 - $75.81
VOLUME [24H]
$327.75K
P/E Ratio
16.40
Earnings per share
$4.52
ISIN
US00182C1036
Price   Prediction

ANI Pharmaceuticals Price Chart

Sorry, that's all we've gotfor now...

ANI Pharmaceuticals ANIP Financial and Trading Overview

ANI Pharmaceuticals stock price 74.17 USD
Previous Close 75.35 USD
Open 75.31 USD
Bid 56.91 USD x 200
Ask 103.53 USD x 200
Day's Range 74.08 - 75.81 USD
52 Week Range 70.15 - 99.5 USD
Volume 327.75K USD
Avg. Volume 334.5K USD
Market Cap 1.7B USD
Beta (5Y Monthly) 0.464
PE Ratio (TTM) 16.409292
EPS (TTM) 4.52 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 108.38 USD

ANIP Valuation Measures

Enterprise Value 1.84B USD
Trailing P/E 16.409292
Forward P/E 7.0398803
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 1.7413609
Price/Book (mrq) 2.6616666
Enterprise Value/Revenue 1.879
Enterprise Value/EBITDA 8.78

Trading Information

ANI Pharmaceuticals Stock Price History

Beta (5Y Monthly) 0.464
52-Week Change -19.28%
S&P500 52-Week Change 18.35%
52 Week High 99.5 USD
52 Week Low 70.15 USD
50-Day Moving Average 80.16 USD
200-Day Moving Average 79.97 USD

ANIP Share Statistics

Avg. Volume (3 month) 334.5K USD
Avg. Daily Volume (10-Days) 337.52K USD
Shares Outstanding 22.96M
Float 19.65M
Short Ratio 8.4
% Held by Insiders 5.45%
% Held by Institutions 107.21%
Shares Short 2.33M
Short % of Float 12.37%
Short % of Shares Outstanding 10.16%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:6

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) June 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 11.07%
Operating Margin (ttm) 14.97%
Gross Margin 60.40%
EBITDA Margin 21.40%

Management Effectiveness

Return on Assets (ttm) 5.44%
Return on Equity (ttm) 20.45%

Income Statement

Revenue (ttm) 978.38M USD
Revenue Per Share (ttm) 47.24 USD
Quarterly Revenue Growth (yoy) 25.90%
Gross Profit (ttm) 590.98M USD
EBITDA 209.41M USD
Net Income Avi to Common (ttm) 99.6M USD
Diluted EPS (ttm) 4.52
Quarterly Earnings Growth (yoy) 189.09%

Balance Sheet

Total Cash (mrq) 376.96M USD
Total Cash Per Share (mrq) 17.59 USD
Total Debt (mrq) 626.03M USD
Total Debt/Equity (mrq) 104.83 USD
Current Ratio (mrq) 2.91
Book Value Per Share (mrq) 27.866

Cash Flow Statement

Operating Cash Flow (ttm) 189.47M USD
Levered Free Cash Flow (ttm) 132.21M USD

Profile of ANI Pharmaceuticals

Country United States
State MN
City Baudette
Address 210 Main Street West
ZIP 56623
Phone 218 634 3500
Website https://www.anipharmaceuticals.com
Industry Drug Manufacturers - Specialty & Generic
Sector(s) Healthcare
Full Time Employees 970

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Q&A For ANI Pharmaceuticals Stock

What is a current ANIP stock price?

ANI Pharmaceuticals ANIP stock price today per share is 74.17 USD.

How to purchase ANI Pharmaceuticals stock?

You can buy ANIP shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for ANI Pharmaceuticals?

The stock symbol or ticker of ANI Pharmaceuticals is ANIP.

Which industry does the ANI Pharmaceuticals company belong to?

The ANI Pharmaceuticals industry is Drug Manufacturers - Specialty & Generic.

How many shares does ANI Pharmaceuticals have in circulation?

The max supply of ANI Pharmaceuticals shares is 22.97M.

What is ANI Pharmaceuticals Price to Earnings Ratio (PE Ratio)?

ANI Pharmaceuticals PE Ratio is 16.40929200 now.

What was ANI Pharmaceuticals earnings per share over the trailing 12 months (TTM)?

ANI Pharmaceuticals EPS is 4.52 USD over the trailing 12 months.

Which sector does the ANI Pharmaceuticals company belong to?

The ANI Pharmaceuticals sector is Healthcare.

ANI Pharmaceuticals ANIP included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.symbol }} {{ item.name }} {{ item.symbol }} {{ item.country.toUpperCase() }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
us US Tech Composite IXIC US 25980.19 USD
-0.77
6.45B USD 25910.82 USD 26109.96 USD 6.45B USD
us US Tech Health Care IXHC US 1361.34 USD
-0.47
1351.98 USD 1363.95 USD
us US Tech Composite Total Return XCMP US 32069.1 USD
-0.76
31983.47 USD 32229.28 USD
us Stlmt ID US Tech Biotechnology NBX US 3995.9 USD
-4.37
4555.41 USD 4917.8 USD
us US Tech Biotechnology Total Retu XNBI US 7916.09 USD
-0.51
7831.07 USD 7930.09 USD
us US Tech Global Market Composite NQGM US 2297.02 USD
-1.82
2285.97 USD 2317.25 USD
us US Tech Biotechnology NBI US 7248.1 USD
-0.51
7170.25 USD 7260.92 USD
$2.66T
Total marketcap
$123B
Total volume
BTC 59.14%     ETH 11.13%
Dominance
Select currency